Regulus Therapeutics Inc.
RGLSDelisted Jun 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001505512
Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Regulus Therapeutics Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- −1 vs. Q1 2023
- Shares held
- 10.2M
- +2.13M (+26.5%) vs. Q1 2023
- Total value
- $15.0M
- +$8.14M (+119.4%) vs. Q1 2023
- New holders
- 1
- 12 more added
- Sold out
- 2
- 1 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RGLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 1 | $760 |
| Q1 2025 | 75 | $107.0M |
| Q4 2024 | 69 | $84.5M |
| Q3 2024 | 70 | $89.1M |
| Q2 2024 | 63 | $109.5M |
| Q1 2024 | 45 | $147.3M |
| Q4 2023 | 26 | $14.2M |
| Q3 2023 | 25 | $15.0M |
| Q2 2023 | 26 | $15.0M |
| Q1 2023 | 27 | $6.82M |
| Q4 2022 | 28 | $11.1M |
| Q3 2022 | 25 | $13.8M |
| Q2 2022 | 28 | $12.6M |
| Q1 2022 | 37 | $18.1M |
| Q4 2021 | 38 | $9.54M |
| Q3 2021 | 42 | $15.9M |
| Q2 2021 | 45 | $18.7M |
| Q1 2021 | 44 | $42.6M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Regulus Therapeutics Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 3,875,578 | $5.70M | 0.01% | +970,752+33.4% | Added |
| FMR LLC | 2,206,600 | $3.24M | 0.00% | +11,600+0.5% | Added |
| NEA Management Company, LLC | 1,945,579 | $2.86M | 0.22% | +500,465+34.6% | Added |
| DAFNA Capital Management LLC | 1,111,049 | $1.63M | 0.45% | +555,494+100.0% | Added |
| Vanguard Group Inc | 282,660 | $415.5K | 0.00% | 00.0% | Unchanged |
| Victory Capital Management Inc | 221,506 | $325.6K | 0.00% | 00.0% | Unchanged |
| Sarissa Capital Management LP | 185,183 | $272.2K | 0.03% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 112,622 | $165.6K | 0.00% | +38,049+51.0% | Added |
| Renaissance Technologies LLC | 46,100 | $68.0K | 0.00% | +7,300+18.8% | Added |
| State Street Corp | 41,719 | $61.3K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 40,660 | $59.8K | 0.00% | +40,660 | New |
| Citadel Advisors LLC | 27,805 | $40.9K | 0.00% | +22,019+380.6% | Added |
| LPL Financial LLC | 18,502 | $27.2K | 0.00% | +5,000+37.0% | Added |
| Northern Trust Corp | 17,978 | $26.4K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 17,500 | $26.0K | 0.00% | 00.0% | Unchanged |
| Grimes & Company, Inc. | 10,363 | $15.2K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,829 | $11.5K | 0.00% | −4,002−33.8% | Reduced |
| UBS Group AG | 3,612 | $5.31K | 0.00% | +1,874+107.8% | Added |
| Community Bank, N.A. | 690 | $1.01K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 618 | $908 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 225 | $331 | 0.00% | +220+4,400.0% | Added |
| Wells Fargo & Company | 127 | $187 | 0.00% | +21+19.8% | Added |
| Advisor Group Holdings, Inc. | 50 | $73 | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 466 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 206 | $0 | 0.00% | +8+4.0% | Added |
| Endurance Wealth Management, Inc. | 675 | $0 | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −18,189−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −492−100.0% | Sold out |